Exonhit Therapeutics entered the industry of Commercial Biotechnical Research in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417110, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact Corinne Hoff, Other by calling (240) 683-7060 during business hours. You can also write to the business’ Single Location at 217 Perry Parkway # 5, Gaithersburg, Maryland MD 20877. You can also visit the company’s website at exonhit.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Exonhit Therapeutics |
Representative: | Corinne Hoff, Other |
Place of Business: | 217 Perry Parkway # 5, Gaithersburg, MD 20877 |
Contact Number: | (240) 683-7060 |
Website: | exonhit.com |
Type of Service: | Commercial Biotechnical Research |
SIC Number: | 8731 |
NAICS Number: | 5417110 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2001 |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Exonhit Therapeutics is a company operating from Montgomery, Maryland providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2001 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 5417110 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Exonhit Therapeutics has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Corinne Hoff, Other at (240) 683-7060 for related queries, or to locate its Single Location using the coordinates 39.14436,-77.21334.
The Single Location can also be found at the street address 217 Perry Parkway # 5 in Gaithersburg, Maryland 20877 and can be engaged online through the company website at exonhit.com, the company Twitter , and Facebook page .